Correction to: Randomized trial of First-Line tyrosine kinase inhibitor with or without radiotherapy for synchronous oligometastatic EGFR-Mutated Non-Small cell lung cancer

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248830/
https://www.ncbi.nlm.nih.gov/pubmed/37203415
http://dx.doi.org/10.1093/jnci/djad084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248830/
https://www.ncbi.nlm.nih.gov/pubmed/37203415
http://dx.doi.org/10.1093/jnci/djad084

Ejemplares similares